Bliss GVS Pharma Limited

Quadrature Capital Vector Sp, which last held a 1.23 percent stake in Bliss GVS Pharma Limited, is no longer listed among the company's disclosed shareholders, indicating either a complete exit or a reduction in their holding to below the 1 percent disclosure threshold.

A pharmaceutical manufacturer engaged in producing and marketing a diverse range of formulations including suppositories, pessaries, capsules, tablets, and syrups. The company operates across manufacturing, marketing, trading, and export functions, serving both domestic and international markets. Established in 1984, it has developed specialized expertise in multiple dosage forms and maintains an integrated operation across the pharmaceutical value chain to address varied healthcare requirements.

India equity vehicle of Quadrature Capital, a London-based quantitative hedge fund.